This inventor holds 1 USPTO granted patent. Top assignees: Daiichi Seiyaku Co., Ltd., Meito Sangyo Co., Ltd.. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 70 
1 out of 6 Years Active: 1991
Title: Innovations of Hideki Miyaji
Introduction
Hideki Miyaji is a notable inventor based in Inazawa, Japan. He has made significant contributions to the field of biochemistry, particularly through his innovative work on mannobiose derivatives. His research has implications for medical applications, especially in targeting liver cells.
Latest Patents
Miyaji holds a patent for a novel mannobiose derivative represented by a specific general formula. This invention includes compounds that provide liposomes with a specific affinity for Kupffer cells of the liver. The compounds can be industrially produced, showcasing their potential for practical applications in medicine.
Career Highlights
Throughout his career, Hideki Miyaji has worked with prominent companies such as Meito Sangyo Co., Ltd. and Daiichi Seiyaku Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biochemistry and patent development.
Collaborations
Miyaji has collaborated with notable colleagues, including Shusaburo Hokukoku and Munehiro Tomikawa. These partnerships have likely enhanced his research and innovation capabilities.
Conclusion
Hideki Miyaji's work on mannobiose derivatives represents a significant advancement in biochemistry. His contributions have the potential to impact medical science positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile